Testing effectiveness (Phase 2)Study completedNCT02860286What this trial is testingStudy of the EZH2 Inhibitor Tazemetostat in Malignant MesotheliomaWho this might be right forMesotheliomaBAP1 Loss of Function Epizyme, Inc. 74